Skip to main content

and
Your search also matched 10 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity

Include preview-only content
  1. Article

    Open Access

    Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

    Matthew D. Galsky, Siamak Daneshmand, Sudeh Izadmehr in Nature Medicine (2024)

  2. Article

    Open Access

    Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

    Cystectomy is a standard treatment for muscle-invasive bladder cancer (MIBC), but it is life-altering. We initiated a phase 2 study in which patients with MIBC received four cycles of gemcitabine, cisplatin, p...

    Matthew D. Galsky, Siamak Daneshmand, Sudeh Izadmehr in Nature Medicine (2023)

  3. Article

    Open Access

    Dissecting microsatellite instability in colorectal cancer: one size does not fit all

    Microsatellite instability (MSI) marks distinct subsets of tumors in many cancer types and is caused by mutations in genes required for mismatch repair. A recent report analyses the molecular foundations of MS...

    Robert M. Samstein, Timothy A. Chan in Genome Medicine (2017)